There are 3162 resources available
1154P - Prospective multinational evaluation of alkylating-induced hypermutation in neuroendocrine neoplasms (NEN): Clinical and molecular profiles associated with response to immune checkpoint inhibitors (CPI)
Presenter: Elena Trevisani
Session: Poster session 17
1156P - The efficacy of lower doses of everolimus in patients with advanced neuroendocrine tumors
Presenter: Rachel Riechelmann
Session: Poster session 17
1157P - Retreatment with peptide receptor radionuclide therapy (PRRT) in patients (p) with neuroendocrine tumors (NET): Spanish clinical experience from SEPTRALU national registry
Presenter: Jorge Hernando Cubero
Session: Poster session 17
1158P - A novel nomogram for predicting overall survival of small intestinal neuroendocrine tumors treated with PRRT
Presenter: Dimitrios Papantoniou
Session: Poster session 17
1159P - Molecular characterization of extra-pulmonary mixed adeno-neuroendocrine carcinomas: The NIRVANA substudy
Presenter: Francesca Spada
Session: Poster session 17
1160P - An Italian multicenter phase II trial of metronomic temozolomide in unfit patients with advanced neuroendocrine neoplasms: Interim analysis of the MeTe study
Presenter: Francesca Spada
Session: Poster session 17
1161P - Progression-free survival ratio and the implications for treatment sequencing in neuroendocrine neoplasms
Presenter: Philipp Melhorn
Session: Poster session 17
1162P - Transcriptomic analysis of gastroenteropancreatic neuroendocrine tumours with carcinoid syndrome
Presenter: Javier Pozas Perez
Session: Poster session 17
1163P - Prognostic value of systemic inflammatory index (SII) in neuroendocrine tumors (NETs) treated with peptide receptor radionuclide therapy (PRRT)
Presenter: Eduardo Terán Brage
Session: Poster session 17